Skip to Content

BT3502: BIO-BUSINESS (2017-2018)

Last modified: 25 May 2018 11:16

Course Overview

  • this course builds on the basic information provided in the introductory course (BT1502);
  • the business models used by the pharmaceutical and biotechnology industry are explained and discussed;
  • the importance of protecting intellectual property rights and the basis of freedom to operate are described;
  • the basics of setting up a technology led business and how to finance this are also developed

Course Details

Study Type Undergraduate Level 3
Session Second Sub Session Credit Points 15 credits (7.5 ECTS credits)
Campus None. Sustained Study No
  • Professor Heather Wallace

Qualification Prerequisites

  • Programme Level 3

What courses & programmes must have been taken before this course?

  • Either BT1501 Introduction to Bio-Business (Passed) or BT1502 Introduction to Bio-Business (Passed)
  • Any Undergraduate Programme (Studied)
  • One of Anatomy (AN) (Studied) or Biochemistry (BC) (Studied) or Biomedical Sciences (BM) (Studied) or Biotechnology (BT) (Studied) or Developmental Biology (DB) (Studied) or Genetics (GN) (Studied) or Immunology (IM) (Studied) or Molecular Biology (MB) (Studied) or Microbiology (MC) (Studied) or Pharmacology (PA) (Studied) or Physiology (PY) (Studied) or Sports Science (SR) (Studied)

What other courses must be taken with this course?


What courses cannot be taken with this course?


Are there a limited number of places available?


Course Description

This course will challenge students to think about the nature of research when driven by commercial outcomes. Many of the future recruitment opportunities for students with medical science skills may involve roles in bio-business development rather than exclusively research at the bench. This course hopes to enable our students to be at a competitive advantage when seeking such career opportunities when compared to those students that only have a traditional scientific background.

A series of lectures and tutorials, together with guest lectures from industry professionals, which will cover the key aspects of different business models in the bio-business sector.

Contact Teaching Time

Information on contact teaching time is available from the course guide.

Teaching Breakdown

More Information about Week Numbers

Details, including assessments, may be subject to change until 31 August 2023 for 1st half-session courses and 22 December 2023 for 2nd half-session courses.

Summative Assessments

1st Attempt: Continuous Assessment (100%).

  • Assessment 1: One 1,500 word essay relating to intellectual property portfolio management.
  • Assessment 2: Following appropriate guidance through tutorials the students will prepare a presentation that describes a medical sciences company of their choice. The emphasis within the presentation will be to sell the commercial entity concentrating on explaining the business model of the chosen business.
  • Assessment 3: One 2,000 word essay. Title will be in the area of competitor analysis of a particular clinical area e.g. cancer therapy.

Resit: 1 one and a half hour essay examination (100%).

Formative Assessment

- Mock presentation to give instant feedback on presentation skills.


- Tutorial sessions will provide feedback on course content. - Written comments will be provided on essays under examination conditions.

Course Learning Outcomes


Compatibility Mode

We have detected that you are have compatibility mode enabled or are using an old version of Internet Explorer. You either need to switch off compatibility mode for this site or upgrade your browser.